About: TOL101

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

TOL101, is a murine-monoclonal antibody specific for the human . In 2010 it was an Investigational New Drug under development by , Inc.

Property	Value
dbo:abstract	TOL101, is a murine-monoclonal antibody specific for the human . In 2010 it was an Investigational New Drug under development by , Inc. (en)
dbo:casNumber	0113923AB
dbo:fdaUniiCode	28X0AGG6P8
dbo:wikiPageExternalLink	http://www.clinicaltrials.gov/ct2/results%3Fterm=tol101 https://www.fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditions/HowtoapplyforOrphanProductDesignation/default.htm
dbo:wikiPageID	28677542 (xsd:integer)
dbo:wikiPageLength	7100 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1107735888 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Cytokine dbr:Cytokine_release_syndrome dbr:Cytomegalovirus dbr:Investigational_New_Drug dbc:Experimental_drugs dbr:T_cell_receptor dbr:Monoclonal dbr:Multiple_sclerosis dbr:Murine dbr:Phase_2_clinical_trial dbr:Anti-thymocyte_globulin dbr:Antibody dbc:Receptor_modulators dbr:Type_1_diabetes dbr:Alemtuzumab dbr:Food_and_Drug_Administration_(United_States) dbr:Otelixizumab dbr:Prophylaxis dbr:Teplizumab dbr:Solid_organ dbc:Antibodies dbc:Immunomodulating_drugs dbr:CD3_(immunology) dbr:Organ_transplantation dbr:Experimental_autoimmune_encephalomyelitis dbr:Immunoreceptor_tyrosine-based_activation_motif dbr:Acute_rejection dbr:Renal_transplant dbr:Γδ_T_cell dbr:Peripheral_blood_monocyte dbr:Tolera_Therapeutics dbr:Αβ_T_cell dbr:Αβ_T_cell_receptor
dbp:casNumber	113923 (xsd:integer)
dbp:chemspiderid	none (en)
dbp:legalUs	Investigational New Drug (en)
dbp:legalUsComment	(en)
dbp:mabType	mab (en)
dbp:routesOfAdministration	Intravenous (en)
dbp:source	o (en)
dbp:target	dbr:T_cell_receptor
dbp:type	mab (en)
dbp:unii	28 (xsd:integer)
dbp:verifiedrevid	451563029 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Authority_control dbt:By_whom dbt:Citation_needed dbt:Drugbox dbt:Portal_bar dbt:Reflist dbt:Update dbt:Use_dmy_dates dbt:Verify_source dbt:When dbt:Cascite dbt:Fdacite
dcterms:subject	dbc:Experimental_drugs dbc:Receptor_modulators dbc:Antibodies dbc:Immunomodulating_drugs
gold:hypernym	dbr:Antibody
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatAntibodies dbo:MonoclonalAntibody yago:Abstraction100002137 yago:Antibody115027189 yago:Chemical114806838 yago:Compound114818238 yago:Macromolecule114944888 yago:Material114580897 yago:Matter100020827 yago:Molecule114682133 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Protein114728724 yago:Relation100031921 dbo:Drug yago:Substance100019613 yago:Thing100002452 yago:Unit109465459
rdfs:comment	TOL101, is a murine-monoclonal antibody specific for the human . In 2010 it was an Investigational New Drug under development by , Inc. (en)
rdfs:label	TOL101 (en)
owl:sameAs	freebase:TOL101 yago-res:TOL101 wikidata:TOL101 https://global.dbpedia.org/id/4vZtD
prov:wasDerivedFrom	wikipedia-en:TOL101?oldid=1107735888&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:TOL101
is dbo:wikiPageWikiLink of	dbr:Investigational_New_Drug
is foaf:primaryTopic of	wikipedia-en:TOL101